New device isolates most aggressive cancer cells

May 23, 2014 by Anne Ju
New device isolates most aggressive cancer cells
Overlay image of the device showing the three channels that sort the cancer cells. Credit: Reinhart-King lab

(Medical Xpress)—Not all cancer cells are created equal – some stay put in the primary tumor, while others move and invade elsewhere. A major goal for cancer research is predicting which cells will metastasize, and why.

A Cornell team is taking a new approach to screening for these dangerous cells, using a microfluidic device they invented that isolates only the most aggressive, .

"The approach we've taken is a reverse approach from what is conventionally done," said Cynthia Reinhart-King, associate professor of biomedical engineering and senior author of the recently published Technology Journal paper describing the research. "Instead of looking at what molecules are being expressed by the tumor, we're looking for the phenotype – that is, the behavior – of individual cells first. Then we can determine what molecules are causing that behavior."

Typically, searching for biomarkers of metastasis has focused on screening for certain molecules or genes expressed by large numbers of migrating . The problem is that it's easy to miss subtle differences in the tiny subpopulations of cells that are the most aggressive.

Taking, for example, 100 tumors and seeking out molecular biomarkers for metastasis, one particular molecule might be identified as being "upregulated" in those tumors, Reinhart-King said. But it's not the whole tumor expressing that particular molecule – some cells express the biomarker and some do not.

New device isolates most aggressive cancer cells
Design of the microfluidic device that sorts for aggressive cancer cells. Credit: Reinhart-King lab

The researchers decided to first sort cells with the most aggressive behavior, and analyze only them for molecular changes. Their innovation is a that contains side channels to wash out the less aggressive cells, while herding the more aggressive ones into a separate channel.

For their proof-of-concept, the researchers screened for cells with migratory responses to Epidermal Growth Factor, for which the receptor is known to be present in most human cancers and is tightly linked to poor prognosis.

"The thing we're most excited about, in addition to the physical device, is the conceptual framework we're using by trying to shift gears and screen for that are causing the worst parts of the disease," Reinhart-King said. The device could also be used in other applications of tissue engineering, inflammation and wound healing.

King collaborated with co-author Michael King; the husband-and-wife team are project leaders in the Cornell Center on the Microenvironment and Metastasis, a National Cancer Institute Physical Sciences-Oncology Center, which supported the work. Authorship includes former postdoctoral associate Saumendra Bajpai and graduate student Michael Mitchell.

Explore further: Ovarian cancer cells are more aggressive on soft tissues

Related Stories

Ovarian cancer cells are more aggressive on soft tissues

May 8, 2014
When ovarian cancer spreads from the ovaries it almost always does so to a layer of fatty tissue that lines the gut. A new study has found that ovarian cancer cells are more aggressive on these soft tissues due to the mechanical ...

Molecule linked to aggressive pancreatic cancer offers potential clinical advances

May 21, 2014
Mayo Clinic researchers have discovered an enzyme they say is tightly linked to how aggressive pancreatic cancer will be in a patient.

Piggy-backing proteins ride white blood cells to wipe out metastasizing cancer

January 6, 2014
Cornell biomedical engineers have discovered a new way to destroy metastasizing cancer cells traveling through the bloodstream – lethal invaders that are linked to almost all cancer deaths – by hitching cancer-killing ...

Bioengineers discover the natural switch that controls spread of breast cancer cells

January 23, 2013
With a desire to inhibit metastasis, Cornell biomedical engineers have found the natural switch between the body's inflammatory response and how malignant breast cancer cells use the bloodstream to spread.

Dormant prostate cancer cells may be reawakened by factors produced in inflammatory cells

January 29, 2014
Researchers in the Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute discovered in pre-clinical models that dormant prostate cancer cells found in bone tissue can be reawakened, causing metastasis to other parts of ...

Decoded: Molecular messages that tell prostate and breast cancers to spread

April 30, 2013
Cancer cells are wily, well-traveled adversaries, constantly side-stepping treatments to stop their spread. But for the first time, scientists at the University of Michigan have decoded the molecular chatter that ramps certain ...

Recommended for you

Shooting the achilles heel of nervous system cancers

July 20, 2017
Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment. A cooperative research team led by researchers at Dartmouth's Norris Cotton Cancer Center ...

Molecular changes with age in normal breast tissue are linked to cancer-related changes

July 20, 2017
Several known factors are associated with a higher risk of breast cancer including increasing age, being overweight after menopause, alcohol intake, and family history. However, the underlying biologic mechanisms through ...

Immune-cell numbers predict response to combination immunotherapy in melanoma

July 20, 2017
Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco ...

Discovery could lead to better results for patients undergoing radiation

July 19, 2017
More than half of cancer patients undergo radiotherapy, in which high doses of radiation are aimed at diseased tissue to kill cancer cells. But due to a phenomenon known as radiation-induced bystander effect (RIBE), in which ...

Definitive genomic study reveals alterations driving most medulloblastoma brain tumors

July 19, 2017
The most comprehensive analysis yet of medulloblastoma has identified genomic changes responsible for more than 75 percent of the brain tumors, including two new suspected cancer genes that were found exclusively in the least ...

Novel CRISPR-Cas9 screening enables discovery of new targets to aid cancer immunotherapy

July 19, 2017
A novel screening method developed by a team at Dana-Farber/Boston Children's Cancer and Blood Disorders Center—using CRISPR-Cas9 genome editing technology to test the function of thousands of tumor genes in mice—has ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.